Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Shares Outstanding (2019 - 2026)

Valneva SE (VALN) posted Shares Outstanding (Entity) of $84.1 million for Q4 2025, down 1.18% sequentially from $85.1 million in Q2 2025, and up 15.42% YoY from $72.9 million in Q4 2024.

Analysis

Valneva SE (VALN) Shares Outstanding (2019 - 2026) Analysis & Trends

Valneva SE has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $84.1 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 15.42% year-over-year to $84.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $84.1 million (up 15.42% YoY) and the FY2025 annual result came in at $84.1 million, up 15.42% from the prior year.
  • Shares Outstanding (Entity) fell to $84.1 million in Q4 2025 per VALN's latest filing, from $85.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $85.1 million in Q2 2025 and troughed at $45.9 million in Q1 2021.
  • A 5-year average of $62.4 million and a median of $58.7 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) climbed 20.05% in 2023, then grew 5.11% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $48.8 million in 2021, then rose by 18.29% to $57.7 million in 2022, then climbed by 20.05% to $69.3 million in 2023, then grew by 5.11% to $72.9 million in 2024, then advanced by 15.42% to $84.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $84.1 million, $85.1 million, and $72.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 84.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.09 Mn
Mar 31, 2026 84.09 Mn
Dec 31, 2025 84.09 Mn
Sep 30, 2025 72.85 Mn
Jun 30, 2025 72.85 Mn
Mar 31, 2025 72.85 Mn
Dec 31, 2024 72.85 Mn
Sep 30, 2024 69.31 Mn
Jun 30, 2024 69.31 Mn
Mar 31, 2024 69.31 Mn
Dec 31, 2023 69.31 Mn
Sep 30, 2023 57.74 Mn
Jun 30, 2023 57.74 Mn
Mar 31, 2023 57.74 Mn
Dec 31, 2022 57.74 Mn
Sep 30, 2022 48.81 Mn
Jun 30, 2022 48.81 Mn
Mar 31, 2022 48.81 Mn
Dec 31, 2021 48.81 Mn
Sep 30, 2021 45.38 Mn